CAJ | 학술논문

随着抗菌药物的广泛应用,鲍曼不动杆菌已出现对氨基糖苷类、氟喹诺酮类、β-内酰胺类等药物耐药,碳青霉烯类抗生素被认为是目前临床治疗鲍曼不动杆菌最有效的药物之一,但近年来耐碳青霉烯类抗生素鲍曼不动杆菌比例逐年增长.此文将对耐碳青霉烯鲍曼不动杆菌的耐药现状、耐药机制及治疗进行综述.
수착항균약물적엄범응용,포만불동간균이출현대안기당감류、불규낙동류、β-내선알류등약물내약,탄청매희류항생소피인위시목전림상치료포만불동간균최유효적약물지일,단근년래내탄청매희류항생소포만불동간균비례축년증장.차문장대내탄청매희포만불동간균적내약현상、내약궤제급치료진행종술.
With the extensive use of antibiotics,Acinetobacter baumannii has appeared resistant to aminoglycosides,fluoroquinolones,beta-lactams and other drugs.Carbapenem antibiotics is considered to be one of the most effecfive drugs in clinical treatment of Acinetobacter baumannii,but carbapenem-resistant Acinetobacter baumannii is increasing gradually in recent years.This review is mainly about the resistant status,resistant mechanisms and treatment of carbapenem-resistant Acinetobacter baumanuii.